Mounjaro
Mounjaro maker wants NHS drug price rises in return for more investment in UK | Pharmaceuticals industry
The US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if ministers agree…
READ FULL STORY